| 1 | 1567915-38-1 | MTI-31 | MTI-31 | C26H30N6O3
| | |
| 2 | 2129515-96-2 | 4-amino-N-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholin-4-ylprop-1-ynyl)pyrrolo[2,3-d]pyrimidine-5-carboxamide | Vepafestinib | C26H30N6O3
| | |
| 3 | 827318-97-8 | Danusertib (PHA-739358) | Danusertib (PHA-739358) | C26H30N6O3
| 标准品;细胞周期;杂环化合物;小分子抑制剂;小分子抑制剂，天然产物 | |
| 4 | 144689-23-6 | 奥美沙坦酯乙酯杂质 | OlMesartan Ethyl Ester IMpurity | C26H30N6O3
| 杂质对照品;对照品-杂质对照品 | |
| 5 | 957490-95-8 | N-[1-(1-adamantyl)-1H-pyrazol-3-yl]-3-({4-nitro-3,5-dimethyl-1H-pyrazol-1-yl}methyl)benzamide | N-[1-(1-adamantyl)-1H-pyrazol-3-yl]-3-({4-nitro-3,5-dimethyl-1H-pyrazol-1-yl}methyl)benzamide | C26H30N6O3
| | |
| 6 | 861393-28-4 | A-740003 | Benzeneacetamide, N-[1-[[(cyanoamino)(5-quinolinylimino)methyl]amino]-2,2-dimethylpropyl]-3,4-dimethoxy- | C26H30N6O3
| | |
| 7 | 1044136-93-7 | 4-(4-甲基-1-哌嗪基)-N-[1,4,5,6-四氢-5-(2-甲氧基-2-苯基乙酰基)吡咯并[3,4-C]吡唑-3-基]苯甲酰胺 | 4-(4-Methyl-1-piperazinyl)-N-[1,4,5,6-tetrahydro-5-(2-methoxy-2-phenylacetyl)pyrrolo[3,4-c]pyrazol-3-yl]benzamide | C26H30N6O3
| | |
| 8 | 916995-51-2 | 4-(4-甲基-1-哌嗪基)-N-[1,4,5,6-四氢-5-[(2S)-2-甲氧基-2-苯基乙酰基]吡咯并[3,4-C]吡唑-3-基]苯甲酰胺 | 4-(4-Methyl-1-piperazinyl)-N-[1,4,5,6-tetrahydro-5-[(2S)-2-methoxy-2-phenylacetyl]pyrrolo[3,4-c]pyrazol-3-yl]benzamide | C26H30N6O3
| | |
| 9 | | 6-amino-8-{3-methoxy-4-[2-(4-morpholinyl)ethoxy]phenyl}-2-methyl-2,3,8,8a-tetrahydro-5,7,7(1H)-isoquinolinetricarbonitrile | 6-amino-8-{3-methoxy-4-[2-(4-morpholinyl)ethoxy]phenyl}-2-methyl-2,3,8,8a-tetrahydro-5,7,7(1H)-isoquinolinetricarbonitrile | C26H30N6O3
| | |
| 10 | 1234480-50-2 | XMD8-92 | 2-[[2-ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one | C26H30N6O3
| 医药中间体;小分子抑制剂;细胞生物学试剂;小分子抑制剂，天然产物 | |